The Drug Discovery Services Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Rising Prevalence of Chronic Diseases to Boost Market Growth Through 2032
The market for drug discovery services is expected to expand due to the rising disease burden in emerging nations, which includes several Middle Eastern and African nations as well as Asia-Pacific nations. These developing nations deal with a wide range of illnesses, including skin conditions, cancer, HIV, cardiovascular, and neurological conditions. It is anticipated that applications for drug discovery services will aid in the control of these illnesses by extending the reach of treatment, assisting patients in following prescribed treatment plans and increasing public awareness of epidemics.
Additionally, COVID-19 offers a chance for the provider of drug discovery services to take on a larger role in healthcare. Over the course of the forecast period, new revenue opportunities for market players are anticipated to be created by the rising number of coronavirus cases around the world and the expanding interaction between technology and healthcare.
What Questions Should You Ask before Buying a Market Research Report?
• How is the drug discovery services market evolving?
• What is driving and restraining the drug discovery services market?
• How will each drug discovery services submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each drug discovery services submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading drug discovery services markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry evolve during the period between 2020 and 2032? What are the implications of drug discovery services projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the drug discovery services market?
• Where is the drug discovery services market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the drug discovery services market today, and over the next 10 years:
• Our 689-page report provides 259 tables and 493 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the drug discovery services market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
The report delivers exclusive COVID-19 variations and economic data specific to your market.
Forecasts to 2032 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising drug discovery services prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Services Type Outlook
• Chemistry Services
• Drug Metabolism and Pharmacokinetics (DMPK)
• Biology Services
Process
• Hit to Lead Identification
• Lead Optimization
• Target Selection
• Target Validation
• Candidate Validation
Drug Type
• Small Molecules
• Biologics
Therapeutic Area
• Oncology
• Neurology
• Infectious and Immune System Diseases
• Cardiovascular Diseases
• Respiratory Diseases
• Digestive System Diseases
• Other Therapeutic Areas
Technology
• High Throughput Screening
• Biochips
• Nanotechnology
• Spectroscopy
• Pharmacogenomics and Pharmacogenetics
• Others
End-user
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• Spain
• United Kingdom
• France
• Italy
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America
• Brazil
• Argentina
• Mexico
• Colombia
• Rest of Latin America
MEA
• GCC
• South Africa
• Rest of MEA
The report also includes profiles and for some of the leading companies in the Drug Discovery
Services Market, 2022 to 2032, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• BioBlocks, Inc
• Charles River Laboratories
• Domainex
• Eurofins Scientific
• Evotec
• Jubilant Pharmova Limited Company
• Labcorp Drug Development (Parent Company Laboratory Corporation of America Holdings)
• Thermo Fisher Scientific Inc.
• Sygnature Discovery
• WuXi AppTec
Overall world revenue for drug discovery services market, 2022 to 2032 in terms of value the market will surpass US$14 billion in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Drug Discovery Services Market, 2022 to 2032 report help you?
In summary, our 680+ page report provides you with the following knowledge:
• Revenue forecasts to 2032 for Drug Discovery Services Market, 2022 to 2032 Market, with forecasts for service type, process, drug type, therapeutic area, technology, and end-user each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2032 for four regional and 23 key national markets – See forecasts for the Drug Discovery Services Market, 2022 to 2032 market in North America, Europe, Asia-Pacific, Latin America and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 10 of the major companies involved in the Drug Discovery Services Market, 2022 to 2032.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the drug discovery services market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.
'
1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Drug Discovery Services Market
1.3 What this Report Delivers
1.4 Why You Should Read this Report
1.5 Key Questions Answered by this Analytical Report Include:
1.6 Who is this Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About
2 Executive Summary
3 Premium Insights
3.1 Geographical Snapshot: Global Drug Discovery Services Market
3.2 Services Segment: Market Attractiveness Index
3.3 Process Segment: Market Attractiveness Index
3.4 Drug Type Segment: Market Attractiveness Index
3.5 Therapeutic Area Segment: Market Attractiveness Index
3.6 Technology Segment: Market Attractiveness Index
3.7 End User Segment: Market Attractiveness Index
4 Market Overview
4.1 Key Findings
4.2 Market Dynamics
4.2.1 Market Driving Factors
4.2.1.1 Rising Prevalence of Chronic Diseases
4.2.1.2 Increase in Research & Development Expenditure for Novel Drug Development
4.2.1.3 High Demand of Outsourcing Clinical Trial Services
4.2.2 Market Restraining Factors
4.2.2.1 Stringent Government Regulations or Approval of New Drug
4.2.2.2 High Cost Associated with New Drug Development
4.2.2.3 High Risk of Failure and Time Consuming Process
4.2.3 Market Opportunities
4.2.3.1 Rise in Healthcare Expenditure
4.2.3.2 Intervention of Artificial Intelligence for Drug Discovery
4.2.3.3 Rise in Growth of Drugs and Biologics
4.3 COVID-19 Impact Analysis
4.3.1 V-Shaped Recovery
4.3.2 U-Shaped Recovery
4.3.3 W-Shaped Recovery
4.3.4 L-Shaped Recovery
4.4 Porter’s Five Forces Analysis
4.4.1 Competitor Rivalry
4.4.2 Threat of Substitute Products
4.4.3 Bargaining Power of Buyers
4.4.4 Threat of New Entrants
4.4.5 Bargaining Power of Suppliers
4.5 PESTEL Analysis
5 Global Drug Discovery Services Market Analysis by Services Type
5.1 Key Findings
5.2 Services Type Segment Growth Prospects
5.3 Global Drug Discovery Services Market Share by Services Type, 2022 & 2032
5.4 Global Drug Discovery Services Market Size Estimation and Forecast by Services Type
5.5 Chemistry Services
5.5.1 Chemistry Services Market Forecast by Region, 2022-2032 (US$ Bn)
5.5.2 Chemistry Services Market Share by Region, 2022 & 2032 (%)
5.6 Drug Metabolism and Pharmacokinetics (DMPK)
5.6.1 Drug Metabolism and Pharmacokinetics (DMPK) Market Forecast by Region, 2022-2032 (US$ Bn)
5.6.2 Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Region, 2022 & 2032 (%)
5.7 Biology Services
5.7.1 Biology Services Market Forecast by Region, 2022-2032 (US$ Bn)
5.7.2 Biology Services Market Share by Region, 2022 & 2032 (%)
6 Global Drug Discovery Services Market Analysis by Process
6.1 Key Findings
6.2 Process Segment Growth Prospects
6.3 Global Drug Discovery Services Market Share by Process, 2022 & 2032
6.4 Hit to Lead Identification
6.4.1 Hit to Lead Identification Market Forecast by Region, 2022-2032 (US$ Bn)
6.4.2 Hit to Lead Identification Market Share by Region, 2022 & 2032 (%)
6.5 Lead Optimization
6.5.1 Lead Optimization Market Forecast by Region, 2022-2032 (US$ Bn)
6.5.2 Lead Optimization Market Share by Region, 2022 & 2032 (%)
6.6 Target Selection
6.6.1 Target Selection Market Forecast by Region, 2022-2032 (US$ Bn)
6.6.2 Target Selection Market Share by Region, 2022 & 2032 (%)
6.7 Target Validation
6.7.1 Target Validation Market Forecast by Region, 2022-2032 (US$ Bn)
6.7.2 Target Validation Market Share by Region, 2022 & 2032 (%)
6.8 Candidate Validation
6.8.1 Candidate Validation Market Forecast by Region, 2022-2032 (US$ Bn)
6.8.2 Candidate Validation Market Share by Region, 2022 & 2032 (%)
6.9 Global Drug Discovery Services Market Size Estimation and Forecast by Process
7 Global Drug Discovery Services Market Analysis by Drug Type
7.1 Key Findings
7.2 Drug Type Segment Growth Prospects
7.3 Global Drug Discovery Services Market Share by Drug Type, 2022 & 2032
7.4 Small Molecules
7.4.1 Small Molecules Market Forecast by Region, 2022-2032 (US$ Bn)
7.4.2 Small Molecules Market Share by Region, 2022 & 2032 (%)
7.5 Biologics
7.5.1 Biologics Market Forecast by Region, 2022-2032 (US$ Bn)
7.5.2 Biologics Market Share by Region, 2022 & 2032 (%)
7.6 Global Drug Discovery Services Market Size Estimation and Forecast by Drug Type
8 Global Drug Discovery Services Market Analysis by Therapeutic Area
8.1 Key Findings
8.2 Therapeutic Area Segment Growth Prospects
8.3 Global Drug Discovery Services Market Share by Therapeutic Area, 2022 & 2032
8.4 Oncology
8.4.1 Oncology Market Forecast by Region, 2022-2032 (US$ Bn)
8.4.2 Oncology Market Share by Region, 2022 & 2032 (%)
8.5 Neurology
8.5.1 Neurology Market Forecast by Region, 2022-2032 (US$ Bn)
8.5.2 Neurology Market Share by Region, 2022 & 2032 (%)
8.6 Infectious and Immune System Diseases
8.6.1 Infectious and Immune System Diseases Market Forecast by Region, 2022-2032 (US$ Bn)
8.6.2 Infectious and Immune System Diseases Market Share by Region, 2022 & 2032 (%)
8.7 Cardiovascular Diseases
8.7.1 Cardiovascular Diseases Market Forecast by Region, 2022-2032 (US$ Bn)
8.7.2 Cardiovascular Diseases Market Share by Region, 2022 & 2032 (%)
8.8 Respiratory Diseases
8.8.1 Respiratory Diseases Market Forecast by Region, 2022-2032 (US$ Bn)
8.8.2 Respiratory Diseases Market Share by Region, 2022 & 2032 (%)
8.9 Digestive System Diseases
8.9.1 Digestive System Diseases Market Forecast by Region, 2022-2032 (US$ Bn)
8.9.2 Digestive System Diseases Market Share by Region, 2022 & 2032 (%)
8.10 Other Therapeutic Areas
8.10.1 Other Therapeutic Areas Market Forecast by Region, 2022-2032 (US$ Bn)
8.10.2 Other Therapeutic Areas Market Share by Region, 2022 & 2032 (%)
8.11 Global Drug Discovery Services Market Size Estimation and Forecast by Therapeutic Area
9 Global Drug Discovery Services Market Analysis by Technology
9.1 Key Findings
9.2 Technology Segment Growth Prospects
9.3 Global Drug Discovery Services Market Share by Technology, 2022 & 2032
9.4 High Throughput Screening
9.4.1 High Throughput Screening Market Forecast by Region, 2022-2032 (US$ Bn)
9.4.2 High Throughput Screening Market Share by Region, 2022 & 2032 (%)
9.5 Biochips
9.5.1 Biochips Market Forecast by Region, 2022-2032 (US$ Bn)
9.5.2 Biochips Market Share by Region, 2022 & 2032 (%)
9.6 Nanotechnology
9.6.1 Nanotechnology Market Forecast by Region, 2022-2032 (US$ Bn)
9.6.2 Nanotechnology Market Share by Region, 2022 & 2032 (%)
9.7 Spectroscopy
9.7.1 Spectroscopy Market Forecast by Region, 2022-2032 (US$ Bn)
9.7.2 Spectroscopy Market Share by Region, 2022 & 2032 (%)
9.8 Pharmacogenomics and Pharmacogenetics
9.8.1 Pharmacogenomics and Pharmacogenetics Market Forecast by Region, 2022-2032 (US$ Bn)
9.8.2 Pharmacogenomics and Pharmacogenetics Market Share by Region, 2022 & 2032 (%)
9.9 Others
9.9.1 Others Market Forecast by Region, 2022-2032 (US$ Bn)
9.9.2 Others Market Share by Region, 2022 & 2032 (%)
9.10 Global drug discovery services market Size Estimation and Forecast by Technology
10 Global Drug Discovery Services Market Analysis by End User
10.1 Key Findings
10.2 End User Segment Growth Prospects
10.3 Global Drug Discovery Services Market Share by End User, 2022 & 2032
10.4 Pharmaceutical and Biotechnology Companies
10.4.1 Pharmaceutical and Biotechnology Companies Market Forecast by Region, 2022-2032 (US$ Bn)
10.4.2 Pharmaceutical and Biotechnology Companies Market Share by Region, 2022 & 2032 (%)
10.5 Academic and Research Institutes
10.5.1 Academic and Research Institutes Market Forecast by Region, 2022-2032 (US$ Bn)
10.5.2 Academic and Research Institutes Market Share by Region, 2022 & 2032 (%)
10.6 Others
10.6.1 Others Market Forecast by Region, 2022-2032 (US$ Bn)
10.6.2 Others Market Share by Region, 2022 & 2032 (%)
10.7 Global Drug Discovery Services Market Size Estimation and Forecast by End User
11 Global Drug Discovery Services Market Analysis by Region
11.1 Key Findings
11.2 Regional Market Size Estimation and Forecast
11.3 COVID-19 Impact Analysis: Recovery Scenarios (V, U, W, L)
12 North America Drug Discovery Services Market Analysis
12.1 Key Findings
12.2 North America Drug discovery services Market Attractiveness Index
12.3 North America Drug Discovery Services Market by Country, 2022, 2027 & 2032 (US$ Bn)
12.4 North America Drug Discovery Services Market Size Estimation and Forecast by Country
12.5 North America Drug discovery services Market Size Estimation and Forecast by Services Type
12.6 North America Drug discovery services Market Size Estimation and Forecast by Process
12.7 North America Drug Discovery Services Market Size Estimation and Forecast by Drug Type
12.8 North America Drug Discovery Services Market Size Estimation and Forecast by Therapeutic Area
12.9 North America Drug Discovery Services Market Size Estimation and Forecast by Technology
12.10 North America Drug Discovery Services Market Size Estimation and Forecast by End User
12.11 U.S. Drug Discovery Services Market Estimation & Forecast
12.11.1 U.S. Drug discovery services Market by Services Type
12.11.2 U.S. Drug Discovery Services Market by Process
12.11.3 U.S. Drug Discovery Services Market by Drug Type
12.11.4 U.S. Drug Discovery Services Market by Therapeutic Area
12.11.5 U.S. Drug Discovery Services Market by Technology
12.11.6 U.S. Drug Discovery Services Market by End User
12.12 Canada Drug Discovery Services Market Estimation & Forecast
12.12.1 Canada Drug Discovery Services Market by Services Type
12.12.2 Canada Drug Discovery Services Market by Process
12.12.3 Canada Drug Discovery Services Market by Drug Type
12.12.4 Canada Drug Discovery Services Market by Therapeutic Area
12.12.5 Canada Drug Discovery Services Market by Technology
12.12.6 Canada Drug Discovery Services Market by End User
13 Europe Drug discovery services Market Analysis
13.1 Key Findings
13.2 Europe Drug Discovery Services Market Attractiveness Index
13.3 Europe Drug Discovery Services Market by Country, 2022, 2027 & 2032 (US$ Bn)
13.4 Europe Drug discovery services Market Size Estimation and Forecast by Country
13.5 Europe Drug Discovery Services Market Size Estimation and Forecast by Services Type
13.6 Europe Drug Discovery Services Market Size Estimation and Forecast by Process
13.7 Europe Drug Discovery Services Market Size Estimation and Forecast by Drug Type
13.8 Europe Drug Discovery Services Market Size Estimation and Forecast by Therapeutic Area
13.9 Europe Drug Discovery Services Market Size Estimation and Forecast By Technology
13.10 Europe Drug Discovery Services Market Size Estimation and Forecast by End User
13.11 Germany Drug Discovery Services Market Estimation & Forecast
13.11.1 Germany Drug Discovery Services Market by Services Type
13.11.2 Germany Drug Discovery Services Market by Process
13.11.3 Germany Drug Discovery Services Market by Drug Type
13.11.4 Germany Drug Discovery Services Market by Therapeutic Area
13.11.5 Germany Drug Discovery Services Market by Technology
13.11.6 Germany Drug Discovery Services Market by End User
13.12 U.K. Drug Discovery Services Market Estimation & Forecast
13.12.1 U.K. Drug Discovery Services Market by Services Type
13.12.2 U.K. Drug Discovery Services Market by Process
13.12.3 U.K. Drug Discovery Services Market by Drug Type
13.12.4 U.K. Drug Discovery Services Market by Therapeutic Area
13.12.5 U.K. Drug Discovery Services Market by Technology
13.12.6 U.K. Drug Discovery Services Market by End User
13.13 France Drug Discovery Services Market Estimation & Forecast
13.13.1 France Drug Discovery Services Market by Services Type
13.13.2 France Drug Discovery Services Market by Process
13.13.3 France Drug Discovery Services Market by Drug Type
13.13.4 France Drug Discovery Services Market by Therapeutic Area
13.13.5 France Drug Discovery Services Market by Technology
13.13.6 France Drug Discovery Services Market by End User
13.14 Italy Drug Discovery Services Market Estimation & Forecast
13.14.1 Italy Drug Discovery Services Market by Services Type
13.14.2 Italy Drug Discovery Services Market by Process
13.14.3 Italy Drug Discovery Services Market by Drug Type
13.14.4 Italy Drug Discovery Services Market by Therapeutic Area
13.14.5 Italy Drug Discovery Services Market by Technology
13.14.6 Italy Drug Discovery Services Market by End User
13.15 Spain Drug Discovery Services Market Estimation & Forecast
13.15.1 Spain Drug Discovery Services Market by Services Type
13.15.2 Spain Drug Discovery Services Market by Process
13.15.3 Spain Drug Discovery Services Market by Drug Type
13.15.4 Spain Drug Discovery Services Market by Therapeutic Area
13.15.5 Spain Drug Discovery Services Market by Technology
13.15.6 Spain Drug Discovery Services Market by End User
13.16 Rest of Europe Drug Discovery Services Market Estimation & Forecast
13.16.1 Rest of Europe Drug Discovery Services Market by Services Type
13.16.2 Rest of Europe Drug Discovery Services Market by Process
13.16.3 Rest of Europe Drug Discovery Services Market by Drug Type
13.16.4 Rest of Europe Drug Discovery Services Market by Therapeutic Area
13.16.5 Rest of Europe Drug Discovery Services Market by Technology
13.16.6 Rest of Europe Drug Discovery Services Market by End User
14 Asia Pacific Drug discovery services Market Analysis
14.1 Key Findings
14.2 Asia Pacific Drug Discovery Services Market Attractiveness Index
14.3 Asia Pacific Drug Discovery Services Market By Country, 2022, 2027 & 2032 (US$ Bn)
14.4 Asia Pacific Drug discovery services Market Size Estimation and Forecast by Country
14.5 Asia Pacific Drug discovery services Market Size Estimation and Forecast by Services Type
14.6 Asia Pacific Drug discovery services Market Size Estimation and Forecast by Process
14.7 Asia Pacific Drug Discovery Services Market Size Estimation and Forecast by Drug Type
14.8 Asia Pacific Drug Discovery Services Market Size Estimation and Forecast by Therapeutic Area
14.9 Asia Pacific Drug Discovery Services Market Size Estimation and Forecast By Technology
14.10 Asia Pacific Drug Discovery Services Market Size Estimation and Forecast By End User
14.11 China Drug Discovery Services Market Estimation & Forecast
14.11.1 China Drug discovery services Market by Services Type
14.11.2 China Drug discovery services Market by Process
14.11.3 China Drug discovery services Market by Drug Type
14.11.4 China Drug discovery services Market by Therapeutic Area
14.11.5 China Drug discovery services Market by Technology
14.11.6 China Drug discovery services Market by End User
14.12 Japan Drug Discovery Services Market Estimation & Forecast
14.12.1 Japan Drug Discovery Services Market by Services Type
14.12.2 Japan Drug Discovery Services Market by Process
14.12.3 Japan Drug Discovery Services Market by Drug Type
14.12.4 Japan Drug Discovery Services Market by Therapeutic Area
14.12.5 Japan Drug Discovery Services Market by Technology
14.12.6 Japan Drug Discovery Services Market by End User
14.13 India Drug Discovery Services Market Estimation & Forecast
14.13.1 India Drug Discovery Services Market by Services Type
14.13.2 India Drug Discovery Services Market by Process
14.13.3 India Drug Discovery Services Market by Drug Type
14.13.4 India Drug Discovery Services Market by Therapeutic Area
14.13.5 India Drug Discovery Services Market by Technology
14.13.6 India Drug Discovery Services Market by End User
14.14 South Korea Drug Discovery Services Market Estimation & Forecast
14.14.1 South Korea Drug Discovery Services Market by Services Type
14.14.2 South Korea Drug Discovery Services Market by Process
14.14.3 South Korea Drug Discovery Services Market by Drug Type
14.14.4 South Korea Drug Discovery Services Market by Therapeutic Area
14.14.5 South Korea Drug Discovery Services Market by Technology
14.14.6 South Korea Drug Discovery Services Market by End User
14.15 Australia Drug Discovery Services Market Estimation & Forecast
14.15.1 Australia Drug Discovery Services Market by Services Type
14.15.2 Australia Drug Discovery Services Market by Process
14.15.3 Australia Drug Discovery Services Market by Drug Type
14.15.4 Australia Drug Discovery Services Market by Therapeutic Area
14.15.5 Australia Drug discovery services Market by Technology
14.15.6 Australia Drug Discovery Services Market by End User
14.16 South East Asia Drug Discovery Services Market Estimation & Forecast
14.16.1 South East Asia Drug Discovery Services Market by Services Type
14.16.2 South East Asia Drug Discovery Services Market by Process
14.16.3 South East Asia Drug Discovery Services Market by Drug Type
14.16.4 South East Asia Drug Discovery Services Market by Therapeutic Area
14.16.5 South East Asia Drug Discovery Services Market by Technology
14.16.6 South East Asia Drug Discovery Services Market by End User
14.17 Rest of Asia Pacific Drug Discovery Services Market Estimation & Forecast
14.17.1 Rest of Asia Pacific Drug Discovery Services Market by Services Type
14.17.2 Rest of Asia Pacific Drug Discovery Services Market by Process
14.17.3 Rest of Asia Pacific Drug Discovery Services Market by Drug Type
14.17.4 Rest of Asia Pacific Drug Discovery Services Market by Therapeutic Area
14.17.5 Rest of Asia Pacific Drug Discovery Services Market by Technology
14.17.6 Rest of Asia Pacific Drug Discovery Services Market by End User
15 Latin America Drug discovery services Market Analysis
15.1 Key Findings
15.2 Latin America Drug Discovery Services Market Attractiveness Index
15.3 Latin America Drug Discovery Services Market by Country, 2022, 2027 & 2032 (US$ Bn)
15.4 Latin America Drug Discovery Services Market Size Estimation and Forecast by Country
15.5 Latin America Drug Discovery Services Market Size Estimation and Forecast by Services Type
15.6 Latin America Drug Discovery Services Market Size Estimation and Forecast by Process
15.7 Latin America Drug Discovery Services Market Size Estimation and Forecast by Drug Type
15.8 Latin America Drug Discovery Services Market Size Estimation and Forecast by Therapeutic Area
15.9 Latin America Drug Discovery Services Market Size Estimation and Forecast by Technology
15.10 Latin America Drug Discovery Services Market Size Estimation and Forecast by End User
15.11 Brazil Drug Discovery Services Market Estimation & Forecast
15.11.1 Brazil Drug Discovery Services Market by Services Type
15.11.2 Brazil Drug Discovery Services Market by Process
15.11.3 Brazil Drug Discovery Services Market by Drug Type
15.11.4 Brazil Drug Discovery Services Market by Therapeutic Area
15.11.5 Brazil Drug Discovery Services Market by Technology
15.11.6 Brazil Drug Discovery Services Market by End User
15.12 Argentina Drug Discovery Services Market Estimation & Forecast
15.12.1 Argentina Drug Discovery Services Market by Services Type
15.12.2 Argentina Drug Discovery Services Market by Process
15.12.3 Argentina Drug Discovery Services Market by Drug Type
15.12.4 Argentina Drug Discovery Services Market by Therapeutic Area
15.12.5 Argentina Drug Discovery Services Market by Technology
15.12.6 Argentina Drug Discovery Services Market by End User
15.13 Mexico Drug Discovery Services Market Estimation & Forecast
15.13.1 Mexico Drug Discovery Services Market by Services Type
15.13.2 Mexico Drug Discovery Services Market by Process
15.13.3 Mexico Drug Discovery Services Market by Drug Type
15.13.4 Mexico Drug Discovery Services Market by Therapeutic Area
15.13.5 Mexico Drug Discovery Services Market by Technology
15.13.6 Mexico Drug Discovery Services Market by End User
15.14 Colombia Drug Discovery Services Market Estimation & Forecast
15.14.1 Colombia Drug Discovery Services Market by Services Type
15.14.2 Colombia Drug Discovery Services Market by Process
15.14.3 Colombia Drug Discovery Services Market by Drug Type
15.14.4 Colombia Drug Discovery Services Market by Therapeutic Area
15.14.5 Colombia Drug Discovery Services Market by Technology
15.14.6 Colombia Drug Discovery Services Market by End User
15.15 Rest of Latin America Drug Discovery Services Market Estimation & Forecast
15.15.1 Rest of Latin America Drug Discovery Services Market by Services Type
15.15.2 Rest of Latin America Drug Discovery Services Market by Process
15.15.3 Rest of Latin America Drug Discovery Services Market by Drug Type
15.15.4 Rest of Latin America Drug Discovery Services Market by Therapeutic Area
15.15.5 Rest of Latin America Drug Discovery Services Market by Technology
15.15.6 Rest of Latin America Drug Discovery Services Market by End User
16 MEA Drug discovery services Market Analysis
16.1 Key Findings
16.2 MEA Drug Discovery Services Market Attractiveness Index
16.3 MEA Drug Discovery Services Market by Country, 2022, 2027 & 2032 (US$ Bn)
16.4 MEA Drug Discovery Services Market Size Estimation and Forecast by Country
16.5 MEA Drug Discovery Services Market Size Estimation and Forecast by Services Type
16.6 MEA Drug Discovery Services Market Size Estimation and Forecast by Process
16.7 MEA Drug Discovery Services Market Size Estimation and Forecast by Drug Type
16.8 MEA Drug Discovery Services Market Size Estimation and Forecast by Therapeutic Area
16.9 MEA Drug Discovery Services Market Size Estimation and Forecast by Technology
16.10 MEA Drug Discovery Services Market Size Estimation and Forecast by End User
16.11 GCC Drug Discovery Services Market Estimation & Forecast
16.11.1 GCC Drug Discovery Services Market by Services Type
16.11.2 GCC Drug Discovery Services Market by Process
16.11.3 GCC Drug Discovery Services Market by Drug Type
16.11.4 GCC Drug Discovery Services Market by Therapeutic Area
16.11.5 GCC Drug Discovery Services Market by Technology
16.11.6 GCC Drug Discovery Services Market by End User
16.12 South Africa Drug Discovery Services Market Estimation & Forecast
16.12.1 South Africa Drug Discovery Services Market by Services Type
16.12.2 South Africa Drug Discovery Services Market by Process
16.12.3 South Africa Drug Discovery Services Market by Drug Type
16.12.4 South Africa Drug Discovery Services Market by Therapeutic Area
16.12.5 South Africa Drug Discovery Services Market by Technology
16.12.6 South Africa Drug Discovery Services Market by End User
16.13 Rest of MEA Drug Discovery Services Market Estimation & Forecast
16.13.1 Rest of MEA Drug Discovery Services Market by Services Type
16.13.2 Rest of MEA Drug Discovery Services Market by Process
16.13.3 Rest of MEA Drug Discovery Services Market by Drug Type
16.13.4 Rest of MEA Drug Discovery Services Market by Therapeutic Area
16.13.5 Rest of MEA Drug Discovery Services Market by Technology
16.13.6 Rest of MEA Drug Discovery Services Market by End User
17 Company Profiles
17.1 Company Share Analysis
17.2 Labcorp Drug Development (Parent Company Laboratory Corporation of America Holdings)
17.2.1 Company Snapshot
17.2.2 Company Overview
17.2.3 Financial Analysis
17.2.3.1 Revenue, 2017-2021
17.2.3.2 Regional Market Shares, 2021
17.2.3.3 Gross Profit, 2017-2021
17.2.4 Product Benchmarking
17.2.5 Strategic Outlook
17.3 Eurofins Scientific
17.3.1 Company Snapshot
17.3.2 Company Overview
17.3.3 Financial Analysis
17.3.3.1 Revenue, 2017-2021
17.3.3.2 Regional Market Shares, 2021
17.3.3.3 Gross Profit, 2017-2021
17.3.4 Product Benchmarking
17.3.5 Strategic Outlook
17.4 Charles River Laboratories International, Inc.
17.4.1 Company Snapshot
17.4.2 Company Overview
17.4.3 Financial Analysis
17.4.3.1 Revenue, 2017-2021
17.4.3.2 Regional Market Shares, 2021
17.4.4 Product Benchmarking
17.4.5 Strategic Outlook
17.5 Evotec AG
17.5.1 Company Snapshot
17.5.2 Company Overview
17.5.3 Financial Analysis
17.5.3.1 Revenue, 2017-2021
17.5.3.2 Gross Profit, 2017-2021
17.5.4 Product Benchmarking
17.5.5 Strategic Outlook
17.6 WuXi AppTec
17.6.1 Company Snapshot
17.6.2 Company Overview
17.6.3 Financial Analysis
17.6.3.1 Revenue, 2015-2021
17.6.3.2 Regional Market Shares, 2021
17.6.4 Product Benchmarking
17.6.5 Strategic Outlook
17.7 Thermo Fisher Scientific Inc.
17.7.1 Company Snapshot
17.7.2 Company Overview
17.7.3 Financial Analysis
17.7.3.1 Revenue, 2017-2021
17.7.3.2 Regional Market Shares, 2021
17.7.4 Product Benchmarking
17.7.5 Strategic Outlook
17.8 Jubilant Pharmova Limited Company
17.8.1 Company Snapshot
17.8.2 Company Overview
17.8.3 Financial Analysis
17.8.3.1 Revenue, 2017-2021
17.8.3.2 Regional Market Shares, 2021
17.8.4 Product Benchmarking
17.8.5 Strategic Outlook
17.9 Domainex
17.9.1 Company Snapshot
17.9.2 Company Overview
17.9.3 Product Benchmarking
17.9.4 Strategic Outlook
17.10 Sygnature Discovery
17.10.1 Company Snapshot
17.10.2 Company Overview
17.10.3 Product Benchmarking
17.10.4 Strategic Outlook
17.11 BioBlocks, Inc
17.11.1 Company Snapshot
17.11.2 Company Overview
17.11.3 Product Benchmarking
18 Conclusion and Recommendations
18.1 Concluding Remarks from
18.2 Recommendations for Market Players
List of Tables
Table 1 Global Drug Discovery Services Market Snapshot, 2022 & 2032 (US$ billion, CAGR %)
Table 2 Global Drug Discovery Services Market by Region, 2022-2032 (USD Bn, AGR (%), CAGR(%)): “V” Shaped Recovery Scenario
Table 3 Global drug discovery services market by Region, 2022-2032 (USD Bn, AGR (%), CAGR(%)): “U” Shaped Recovery Scenario
Table 4 Global Drug Discovery Services Market By Region, 2022-2032 (USD Bn, AGR (%), CAGR(%)): “W” Shaped Recovery Scenario
Table 5 Global Drug Discovery Services Market By Region, 2022-2032 (USD Bn, AGR (%), CAGR(%)): “L” Shaped Recovery Scenario
Table 6 Global Drug Discovery Services Market by Services Type Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 7 Chemistry Services Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 8 Drug Metabolism and Pharmacokinetics (DMPK) Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 9 Biology Services Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 10 Hit to Lead Identification Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 11 Lead Optimization Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 12 Target Selection Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 13 Target Validation Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 14 Candidate Validation Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 15 Global Drug Discovery Services Market by Services Process Forecast, 2022-2032
(US$ Bn, AGR%, CAGR%)
Table 16 Small Molecules Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 17 Biologics Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 18 Global Drug Discovery Services Market by Drug Type Forecast, 2022-2032
(US$ Bn, AGR%, CAGR%)
Table 19 Oncology Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 20 Neurology Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 21 Infectious and Immune System Diseases Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 22 Cardiovascular Diseases Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 23 Respiratory Diseases Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 24 Digestive System Diseases Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 25 Other Therapeutic Areas Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 26 Global Drug Discovery Services Market by Therapeutic Area Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 27 High Throughput Screening Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 28 Biochips Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 29 Nanotechnology Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 30 Spectroscopy Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 31 Pharmacogenomics And Pharmacogenetics Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 32 Others Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 33 Global Drug Discovery Services Market by Technology Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 34 Pharmaceutical and Biotechnology Companies Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 35 Academic and Research Institutes Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 36 Others Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 37 Global Drug Discovery Services Market by End User Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 38 Global Drug Discover Services Market by Region Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 39 Global drug discovery services market by Region, 2022-2032 (USD Bn, AGR (%), CAGR(%)): “V” Shaped Recovery Scenario
Table 40 Global Drug Discovery Services Market by Region, 2022-2032 (USD Bn, AGR (%), CAGR(%)): “U” Shaped Recovery Scenario
Table 41 Global Drug Discovery Services Market by Region, 2022-2032 (USD Bn, AGR (%), CAGR(%)): “W” Shaped Recovery Scenario
Table 42 Global Drug Discovery Services Market by Region, 2022-2032 (USD Bn, AGR (%), CAGR(%)): “L” Shaped Recovery Scenario
Table 43 North America Drug Discovery Services Market Forecast By Country, 2022-2032 (US$ Billion, AGR (%)
Table 44 North America Drug Discovery Services Market by Services Type Forecast,
2022-2032 (US$ Mn, AGR%, CAGR%)
Table 45 North America Drug Discovery Services Market by Services Process Forecast,
2022-2032 (US$ Mn, AGR%, CAGR%)
Table 46 North America Drug Discovery Services Market by Drug Type Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 47 North America Drug Discovery Services Market by Therapeutic Area Forecast,
2022-2032 (US$ Mn, AGR%, CAGR%)
Table 48 North America Drug Discovery Services Market by Technology Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 49 North America Drug Discovery Services Market by End User Forecast, 2022-2032
(US$ Mn, AGR%, CAGR%)
Table 50 U.S. Drug Discovery Services Market by Country Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 51 U.S. Drug Discovery Services Market by Services Type Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 52 U.S. Drug Discovery Services Market by Process Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 53 U.S. Drug Discovery Services Market by Drug Type Forecast, 2022-2032
(US$ Mn, AGR%, CAGR%)
Table 54 U.S. Drug Discovery Services Market by Therapeutic Area Forecast, 2022-2032
(US$ Mn, AGR%, CAGR%)
Table 55 U.S. Drug Discovery Services Market by Technology Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 56 U.S. Drug Discovery Services Market by End User Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 57 Canada Drug Discovery Services Market by Country Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 58 Canada Drug Discovery Services Market by Services Type Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 59 Canada Drug Discovery Services Market by Services Process Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 60 Canada Drug Discovery Services Market by Drug Type Forecast,
2022-2032 (US$ Mn, AGR%, CAGR%)
Table 61 Canada Drug Discovery Services Market by Therapeutic Area Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 62 Canada Drug Discovery Services Market by Technology Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 63 Canada Drug Discovery Services Market by End User Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 64 Europe Drug Discovery Services Market by Country Forecast, 2022-2032
(US$ Bn, AGR%, CAGR%)
Table 65 Europe Drug Discovery Services Market by Services Type Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 66 Europe Drug Discovery Services Market by Services Process Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
Table 67 Europe Drug Discovery Services Market by Drug Type Forecast, 2022-2032 (US$ Bn, AGR
